Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Doxorubicin in childhood cancer increases subsequent cardiac risk

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Doxorubicin in childhood cancer increases subsequent cardiac risk. React. Wkly. 1011, 5 (2004). https://doi.org/10.2165/00128415-200410110-00004

    Download citation

    Keywords

    • Heart Failure
    • Relative Risk
    • Doxorubicin
    • Congestive Heart Failure
    • Cardiac Disease